ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
Dow Jones
39.150,33
0,04%
Euro vs US Dollar
1,06863
-0,06%
Bitcoin
64.074,72
-0,27%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Silk Road Medical Inc (SILK)

  7. Silk Road Medical Inc (SILK) News

SILK

Silk Road Medical (SILK)

Silk Road Medical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SILK
DatumZeitQuelleÜberschriftSymbolFirma
18/06/202423h20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SILKSilk Road Medical Inc
18/06/202423h16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SILKSilk Road Medical Inc
18/06/202423h12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SILKSilk Road Medical Inc
18/06/202423h11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SILKSilk Road Medical Inc
18/06/202422h40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SILKSilk Road Medical Inc
18/06/202422h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SILKSilk Road Medical Inc
18/06/202419h23PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.NASDAQ:SILKSilk Road Medical Inc
18/06/202413h00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.NASDAQ:SILKSilk Road Medical Inc
18/06/202413h00GlobeNewswire Inc.Silk Road Medical Announces Definitive Agreement to be Acquired by Boston ScientificNASDAQ:SILKSilk Road Medical Inc
30/05/202422h12Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:SILKSilk Road Medical Inc
07/05/202422h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SILKSilk Road Medical Inc
30/04/202422h05GlobeNewswire Inc.Silk Road Medical Reports First Quarter 2024 Financial ResultsNASDAQ:SILKSilk Road Medical Inc
23/04/202422h30GlobeNewswire Inc.Silk Road Medical to Present at the BofA Securities 2024 Healthcare ConferenceNASDAQ:SILKSilk Road Medical Inc
09/04/202422h30GlobeNewswire Inc.Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:SILKSilk Road Medical Inc
02/04/202422h30GlobeNewswire Inc.Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSNASDAQ:SILKSilk Road Medical Inc
07/03/202412h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILKSilk Road Medical Inc
06/03/202401h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILKSilk Road Medical Inc
06/03/202401h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILKSilk Road Medical Inc
06/03/202400h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILKSilk Road Medical Inc
06/03/202400h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILKSilk Road Medical Inc
06/03/202400h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILKSilk Road Medical Inc
05/03/202423h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SILKSilk Road Medical Inc
05/03/202422h58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SILKSilk Road Medical Inc
05/03/202422h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SILKSilk Road Medical Inc
05/03/202415h00GlobeNewswire Inc.Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent SystemNASDAQ:SILKSilk Road Medical Inc
05/03/202400h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILKSilk Road Medical Inc
29/02/202420h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SILKSilk Road Medical Inc
28/02/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SILKSilk Road Medical Inc
28/02/202422h05GlobeNewswire Inc.Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial OutlookNASDAQ:SILKSilk Road Medical Inc
07/02/202422h30GlobeNewswire Inc.Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:SILKSilk Road Medical Inc
 Showing the most relevant articles for your search:NASDAQ:SILK

Kürzlich von Ihnen besucht

USOTC
DTEGY
Deutsche Telekom (QX)
TG
MBG
MercedesBenz
NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
FX
EURUSD
Euro vs US Dollar
COIN
SOLUSD
Solana
NASDAQ
AMZN
Amazon.com
USOTC
ADDYY
Adidas (QX)
FX
EURJPY
Euro vs Yen
TG
CBK
Commerzbank
NYSE
NKE
Nike
NASDAQ
AAPL
Apple
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten